• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 424B5 filed by Exelon Corporation

    6/20/25 3:23:06 PM ET
    $EXC
    Power Generation
    Utilities
    Get the next $EXC alert in real time by email
    424B5 1 excprospectussupplement424.htm 424B5 Document

    Filed Pursuant to Rule 424(b)(5)
    Registration No. 333-222989
    PROSPECTUS SUPPLEMENT
    (To Prospectus Dated February 12, 2018)


    Explanatory Note
    This prospectus supplement is being filed solely for the purpose of amending and restating the cover page and Appendix B to the prospectus supplement filed by Exelon with the Securities and Exchange Commission in connection with the Plan under the Securities Act of 1933 on June 30, 2023. The amended and restated Appendix B will take effect on August 1, 2025.
    1


    PROSPECTUS
    image_0a.jpg


    EXELON CORPORATION
    DIRECT STOCK PURCHASE PLAN

    We hereby offer participation in our Direct Stock Purchase Plan, or the Plan. The Plan is designed to provide investors with a convenient way to purchase shares of our common stock and to reinvest in our common stock all or a portion of the cash dividends paid on our common stock.
    Our common shares are listed on NASDAQ under the symbol “EXC.”
    Investing in shares of our common stock involves risks. Please see “Risk Factors” beginning on page 3 for a discussion of factors you should consider before investing in our common stock under the Plan.
    Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the Securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
    This prospectus relates to all shares acquired by participants under the Plan. Shares available under the Plan will be shares purchased on the open market by a registered broker selected by us, newly issued shares or treasury shares. All shares acquired by participants under the Plan are registered for sale pursuant to a registration statement that we filed with the Securities and Exchange Commission.


    image_1a.jpg


    The date of this prospectus is June 20, 2025.

    2


    Appendix B

    INVESTMENT SUMMARY AND SERVICE FEES
    Summary
    Minimum cash investments
    Minimum one-time initial purchase for new investors    $250.00
    Minimum one-time optional cash investment    $50.00
    Minimum recurring automatic investments    $50.00
    Maximum cash investments
    Maximum monthly investment    $20,000.00
    Dividend reinvestment options
    Reinvest options    Full, Partial
    Fees
    Investment fees
    Initial enrollment (new investors only)    $15.00
    Dividend reinvestment    3% / $3.00 max
    Check investment    Company Paid
    One-time automatic investment    Company Paid
    Recurring automatic investment    Company Paid
    Dividend purchase trading commission per share    $0.07
    Optional cash purchase trading commission per share    $0.07
    Sales fees
    Batch Order    $15.00
    Market Order    $25.00
    Limit Order per transaction (Day/GTD/GTC)    $30.00
    Stop Order    $30.00
    Sale trading commission per share    $0.12
    Direct deposit of sale proceeds    $5.00
    Other fees
    Certificate deposit    Company Paid
    Returned check / Rejected automatic bank withdrawals    $35.00 per item
    Prior year duplicate statements    $15.00 per year
    3
    Get the next $EXC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EXC

    DatePrice TargetRatingAnalyst
    5/14/2025$39.00Sector Weight → Underweight
    KeyBanc Capital Markets
    4/15/2025$48.00Outperform → In-line
    Evercore ISI
    1/23/2025Neutral → Buy
    Guggenheim
    1/21/2025$43.00 → $44.00In-line → Outperform
    Evercore ISI
    9/20/2024$46.00Buy
    Jefferies
    1/10/2024$36.00 → $39.00Neutral → Buy
    Mizuho
    1/8/2024Buy → Neutral
    Seaport Research Partners
    1/2/2024$47.00 → $37.00Buy → Neutral
    UBS
    More analyst ratings